114 related articles for article (PubMed ID: 36689919)
1. GNRI Sustainability during One Cycle of First-Line Chemotherapy as a Prognostic Indicator in Patients with Metastatic Urothelial Carcinoma.
Sugiyama Y; Naiki T; Tasaki Y; Mimura Y; Etani T; Noda Y; Nozaki S; Shimizu N; Banno R; Nagai T; Isobe T; Ando R; Moritoki Y; Kataoka T; Odagiri K; Aoki M; Gonda M; Yasui T; Hibi Y
Oncology; 2023; 101(4):224-233. PubMed ID: 36689919
[TBL] [Abstract][Full Text] [Related]
2. Low Geriatric Nutritional Risk Index as a Poor Prognostic Marker for Second-Line Pembrolizumab Treatment in Patients with Metastatic Urothelial Carcinoma: A Retrospective Multicenter Analysis.
Etani T; Naiki T; Sugiyama Y; Nagai T; Iida K; Noda Y; Shimizu N; Tasaki Y; Mimura Y; Okada T; Banno R; Kubota H; Hamamoto S; Ando R; Kawai N; Yasui T
Oncology; 2020; 98(12):876-883. PubMed ID: 32862183
[TBL] [Abstract][Full Text] [Related]
3. First Report of Oncological Outcome and Prognostic Analysis in a First-Line Setting of Short Hydration Gemcitabine and Cisplatin Chemotherapy for Patients with Metastatic Urothelial Carcinoma.
Naiki T; Nagai T; Sugiyama Y; Etani T; Nozaki S; Iida K; Noda Y; Shimizu N; Isobe T; Matsumoto D; Kubota H; Hamamoto S; Ando R; Kawai N; Yasui T
Oncology; 2021; 99(10):622-631. PubMed ID: 34284409
[TBL] [Abstract][Full Text] [Related]
4. Chronological transition in outcome of second-line treatment in patients with metastatic urothelial cancer after pembrolizumab approval: a multicenter retrospective analysis.
Isobe T; Naiki T; Sugiyama Y; Naiki-Ito A; Nagai T; Etani T; Nozaki S; Iida K; Noda Y; Shimizu N; Tomiyama N; Banno R; Kubota H; Hamamoto S; Ando R; Kawai N; Yasui T
Int J Clin Oncol; 2022 Jan; 27(1):165-174. PubMed ID: 34633579
[TBL] [Abstract][Full Text] [Related]
5. Association of the Geriatric Nutritional Risk Index with the survival of patients with non-small-cell lung cancer after platinum-based chemotherapy.
Karayama M; Inoue Y; Yasui H; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Enomoto N; Nakamura Y; Inui N; Suda T
BMC Pulm Med; 2021 Dec; 21(1):409. PubMed ID: 34895201
[TBL] [Abstract][Full Text] [Related]
6. The Geriatric Nutritional Risk Index is a prognostic marker in patients with metastatic colorectal cancer.
Kato R; Miyamoto Y; Ouchi M; Ogawa K; Yoshida N; Baba H
Int J Clin Oncol; 2023 Jul; 28(7):893-900. PubMed ID: 37072628
[TBL] [Abstract][Full Text] [Related]
7. Skeletal Muscle Mass Reduction Velocity as a Simple Prognostic Indicator for Patients with Metastatic Urothelial Carcinoma Receiving Second-Line Chemotherapy.
Nagai T; Naiki T; Iida K; Nozaki S; Etani T; Sugiyama Y; Ando R; Yanase T; Chaya R; Moritoki Y; Kobayashi D; Akita H; Okamura T; Yasui T
Asian Pac J Cancer Prev; 2019 Oct; 20(10):2995-3000. PubMed ID: 31653146
[TBL] [Abstract][Full Text] [Related]
8. The Geriatric Nutritional Risk Index (GNRI) as a Prognostic Biomarker for Immune Checkpoint Inhibitor Response in Recurrent and/or Metastatic Head and Neck Cancer.
Haas M; Lein A; Fuereder T; Brkic FF; Schnoell J; Liu DT; Kadletz-Wanke L; Heiduschka G; Jank BJ
Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839241
[TBL] [Abstract][Full Text] [Related]
9. Geriatric Nutritional Risk Index as a prognostic factor in patients with esophageal squamous cell carcinoma -retrospective cohort study.
Yamana I; Takeno S; Shimaoka H; Yamashita K; Yamada T; Shiwaku H; Hashimoto T; Yamashita Y; Hasegawa S
Int J Surg; 2018 Aug; 56():44-48. PubMed ID: 29602015
[TBL] [Abstract][Full Text] [Related]
10. Second-Line Chemotherapy for Metastatic Urothelial Carcinoma: Importance of Lymph Node-Only Metastasis as a Prognostic Factor and Construction of a Prognostic Model.
Salah S; Lee JL; Rozzi A; Kitamura H; Matsumoto K; Srinivas S; Morales-Barrera R; Carles J; Al-Wardat R; Al-Rabi K; Maakoseh M
Clin Genitourin Cancer; 2016 Jun; 14(3):255-60. PubMed ID: 26552764
[TBL] [Abstract][Full Text] [Related]
11. A Phase II Study of Weekly Docetaxel as Second-Line Chemotherapy in Patients With Metastatic Urothelial Carcinoma.
Kim YS; Lee SI; Park SH; Park S; Hwang IG; Lee SC; Sun JM; Lee J; Lim HY
Clin Genitourin Cancer; 2016 Feb; 14(1):76-81. PubMed ID: 26454620
[TBL] [Abstract][Full Text] [Related]
12. Geriatric nutritional risk index predicts prognosis in hepatocellular carcinoma after hepatectomy: a propensity score matching analysis.
Kanno H; Goto Y; Sasaki S; Fukutomi S; Hisaka T; Fujita F; Akagi Y; Okuda K
Sci Rep; 2021 Apr; 11(1):9038. PubMed ID: 33907232
[TBL] [Abstract][Full Text] [Related]
13. Geriatric nutritional risk index predicts all-cause deaths in heart failure with preserved ejection fraction.
Nishi I; Seo Y; Hamada-Harimura Y; Yamamoto M; Ishizu T; Sugano A; Sato K; Sai S; Obara K; Suzuki S; Koike A; Aonuma K; Ieda M;
ESC Heart Fail; 2019 Apr; 6(2):396-405. PubMed ID: 30706996
[TBL] [Abstract][Full Text] [Related]
14. Geriatric Nutritional Risk Index as a prognostic marker in patients with extensive-stage disease small cell lung cancer: Results from a randomized controlled trial.
Lee GW; Go SI; Kim DW; Kim HG; Kim JH; An HJ; Jang JS; Kim BS; Hahn S; Heo DS
Thorac Cancer; 2020 Jan; 11(1):62-71. PubMed ID: 31707767
[TBL] [Abstract][Full Text] [Related]
15. The geriatric nutritional risk index independently predicts adverse outcomes in patients with pyogenic liver abscess.
Xu J; Zhou X; Zheng C
BMC Geriatr; 2019 Jan; 19(1):14. PubMed ID: 30651062
[TBL] [Abstract][Full Text] [Related]
16. The Geriatric Nutritional Risk Index is Independently Associated with Prognosis in Patients with Critical Limb Ischemia Following Endovascular Therapy.
Shiraki T; Iida O; Takahara M; Masuda M; Okamoto S; Ishihara T; Nanto K; Kanda T; Fujita M; Uematsu M
Eur J Vasc Endovasc Surg; 2016 Aug; 52(2):218-24. PubMed ID: 27357968
[TBL] [Abstract][Full Text] [Related]
17. Prognostic model in patients with metastatic urothelial carcinoma receiving immune checkpoint inhibitors after platinum failure.
Park JH; Park I; Kim IH; Hur JY; Hwang I; Kim C; Kim HJ; Maeng CH; Park K; Lee MY; Lee HJ; Jung JY; Keam B; Park SH; Lee JL
Curr Probl Cancer; 2022 Jun; 46(3):100848. PubMed ID: 35344842
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in patients with advanced transitional cell carcinoma of the urothelial tract experiencing treatment failure with platinum-containing regimens.
Bellmunt J; Choueiri TK; Fougeray R; Schutz FA; Salhi Y; Winquist E; Culine S; von der Maase H; Vaughn DJ; Rosenberg JE
J Clin Oncol; 2010 Apr; 28(11):1850-5. PubMed ID: 20231682
[TBL] [Abstract][Full Text] [Related]
19. Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial.
Powles T; Csőszi T; Özgüroğlu M; Matsubara N; Géczi L; Cheng SY; Fradet Y; Oudard S; Vulsteke C; Morales Barrera R; Fléchon A; Gunduz S; Loriot Y; Rodriguez-Vida A; Mamtani R; Yu EY; Nam K; Imai K; Homet Moreno B; Alva A;
Lancet Oncol; 2021 Jul; 22(7):931-945. PubMed ID: 34051178
[TBL] [Abstract][Full Text] [Related]
20. Does the geriatric nutrition risk index predict the prognosis of patients with oral squamous cell carcinoma?
Yamagata K; Fukuzawa S; Uchida F; Terada K; Ishibashi-Kanno N; Bukawa H
Br J Oral Maxillofac Surg; 2022 May; 60(4):475-481. PubMed ID: 35086741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
